Abstract Recent human clinical trials results demon-
Introduction
Cystic fibrosis (CF) is the most common fatal genetic disease in the western world, with an incidence of approximately 1 in 2,500 births [1] . CF is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that encodes a chloride channel belonging to the ATP-binding cassette (ABC) transporter superfamily [2, 3] . Defects of CFTR channel function compromise epithelial transcellular fluid regulation in the lungs, pancreas, and other organs, and lead to thickening of mucus in the lungs, and eventually tissue sequelae and death. Other complications of CF include malnutrition due to pancreatic insufficiency, electrolyte imbalances, diabetes, and male infertility. The most frequent genetic mutation associated with clinical CF disease is deletion of phenylalanine at position 508 (DF508) in CFTR. The DF508 mutation results in aberrant folding of the CFTR protein, retention of CFTR in the endoplasmic reticulum, and premature CFTR protein degradation [4] . Interestingly, wild-type CFTR (wtCFTR) appears to fold, mature, and reach the plasma membrane less efficiently compared to other ABC transporters [5] [6] [7] . Cellular quality control appears to be quite stringent, and even mature CFTR at the cell surface is endocytosed at a rate of *10 % per min in normal cells [8] . N-glycosylation is intimately linked with CFTR folding in the endoplasmic reticulum, and maturation in the Golgi apparatus of glycan chains from the core-glycosylated form (band B) of CFTR to the final complex-glycosylated form (band C) often is used experimentally as a surrogate for proper CFTR folding and trafficking to the cell surface [6, 9] .
The architecture of CFTR is similar to that of other ABC transporters, consisting of transmembrane domains harboring the chloride pore, connected by cytoplasmic loops to two nucleotide-binding domains (NBDs) that hydrolyze ATP [10, 11] . CFTR features a unique regulatory (R) region that, when phosphorylated, regulates ATP hydrolysis-mediated channel gating [7, 12] . Limited insights toward understanding this complex structure, interactions between subdomains, and preliminary functional models have been provided by low-resolution structures of full-length CFTR, crosslinking experiments, nuclear magnetic resonance studies of partial molecules, and molecular modeling based on crystal structures of other ABC transporters [13] [14] [15] [16] .
Drug discovery efforts based on a variety of CFTR 'correctors' that improve trafficking of misfolded protein to the plasma membrane or 'potentiators' that improve channel function [17] were initially disappointing due to poor potency of the compounds [18] [19] [20] . However, the recent FDA approval and clinical success using ivacaftor to treat CF patients with CFTR gating mutations (http://www. fda.gov/drugs/scienceresearch/researchareas/pharmacoge netics/ucm290088.htm) firmly validate rationale for the discovery of small-molecule CF drugs. Since patients with gating mutations and other mutations that can be treated with ivacaftor represent fewer than 15 % of the over 1,900 CF-causing mutations identified to date (http://www.cftr2. org/), it seems likely that additional CF drugs will be needed to extend treatment opportunities to greater numbers of individuals afflicted with CF [21] . To augment drug discovery, direct structural and biophysical characterization of wild-type and mutated forms of CFTR is urgently needed, but has been impeded by both difficulties producing significant quantities of CFTR and the limited stability of purified protein. The goal of the present study was to characterize a molecular expression strategy that was conceived to facilitate the identification and derivation of stable cell lines for high-level production of full-length CFTR. Our results demonstrated robust expression in human embryonic kidney (HEK) epithelial cells of exogenous full-length human CFTR comprising various domains and tags that facilitate the derivation of stable high-producer cell lines, assessment of CFTR biogenesis, and characterization of recombinant CFTR protein. These findings are significant as they demonstrate a mammalian cell expression system capable of producing human CFTR of sufficient quality and quantity to support biophysical and structural studies.
Materials and Methods

CFTR Expression Vectors
Schematics of the HIV-1-based lentiviral vectors used in these studies are shown in Fig. 1 . The basic molecular genetic structure of these vectors included LTR-w-RRE-CTS/PPT-TRE-MCS-IRES-Puro-WPRE-DU3.LTR (LTR, long-terminal repeat; w, psi/RNA genome packaging signal; RRE, Rev response element; CTS, central termination sequence; PPT, polypurine tract; TRE, tetracycline-response element; MCS, multiple cloning site; IRES, internal ribosome entry site; Puro, puromycin N-acetyl-transferase gene; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; and DU3.LTR, deletion in the U3 sequence of the LTR). Most of these genetic elements have been described previously [22] [23] [24] [25] [26] [27] [28] . The arrangement of the TRE and IRES allows genes inserted into the MCS and those downstream of the IRES to be expressed from a single mRNA transcript.
The TRE-CFTR-IRES-Puro.T2A.EGFP vector (K2933) was derived from a wtCFTR expression vector described previously [29] by inserting a Puro element followed by a Thosea asigna 2A-like peptide (T2A) coding sequence upstream and in-frame with enhanced green fluorescent protein (EGFP) [30] [31] [32] . The CFTR FLAG-containing expression vector, TRE-CFTR FLAG -IRES-Puro (K3103) was created by polymerase chain reaction (PCR) amplification of a CFTR sequence containing the FLAG octapeptide epitope (DYKDDDDK) after residue N901 [33, 34] , and its ligation into the 5 0 NheI and 3 0 XhoI sites of the lentiviral vector. Published studies indicate that inclusion of a FLAG tag in the 4th extracellular loop (proximal to residue 901) enables cell-surface localization of CFTR without altering its expression [33, 34] . The expression vector, TRE-CFTR FLAG -EGFP-IRESPuro (K3290), was generated by ligating an A206K-mutated EGFP [25] sequence in-frame and downstream of CFTR FLAG . The translational stop codon of CFTR was eliminated and a tobacco etch virus (TEV) protease cleavage site (underlined) [35] , and a glycine-serine hinge were introduced between the CFTR FLAG and EGFP genes (CFTR FLAG -ENLYFQGGGGSGGSS-EGFP). The TRE-SUMO*-CFTR FLAG -EGFP-IRES-Puro expression vector (K3235) was generated by inserting a DNA segment coding for MERGSH10-LVPRGSAS-SUMOstar (synthesized by GeneArt/Life Sciences) in-frame at the 5 0 end of CFTR FLAG -EGFP. The N-terminal RGSHis 10 tag enables affinity purification and immunodetection of the recombinant protein. The His-tag is cleavable by the presence of a Thrombin protease cleavage site (underlined). Small ubiquitin-like modifier (SUMO, Saccharomyces cerevisiae Smt3), and SUMOstar (SUMO*) domains have been shown to enhance folding and solubility of fused recombinant proteins [36, 37] , including isolated CFTR NBDs [38] . SUMO* is modified at two interfacial amino acids, R64T and R71E, rendering resistance to cleavage by intrinsic eukaryotic proteases [39] . The SUMO* polypeptide can be removed from its fusion partner with specific proteases [37, 40] . The integrity of each of the recombinant expression vectors was confirmed by nucleotide sequence analysis. The entire ORF sequence of SUMO*-CFTR FLAG -EGFP was deposited in GenBank (accession KP202880). , and RGSHis 10 -SUMO*-tagged CFTR-EGFP (SUMO*-CFTR-EGFP). EGFP encodes the A206K mutation to minimize self-dimerization [25] .
Each of the illustrated expression cassettes represents a genetic sequence inserted into a lentiviral vector for delivery and stable integration into HEK293.M2 cells. These vectors contain a TRE promoter followed by CFTR sequence, IRES, and either the puromycin resistance gene or a puromycin-T2A-EGFP open reading frame. T2A, a member of the 2A peptide family, comprises a 19 amino acid sequence that causes a co-translational separation in the synthesis of the puromycin and EGFP polypeptides [30] [31] [32] Cell Lines and Growth Conditions HEK293 (293F; Invitrogen), HEK293.M2 (D017) [41] , and cell lines derived from HEK293.M2 cells by lentiviral vector transduction were maintained as adherent cultures in DMEM/F12 medium supplemented to contain 10 % fetal bovine serum (FBS) (HyClone), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (Life Technologies). The HEK293.M2 cell line [41] constitutively expresses a modified form of the reverse tetracycline transactivator (rtTA-M2) for specific and sensitive doxycycline (dox)-inducible gene expression under control of the tetracyclineresponse element [42] . All HEK293-derived cell lines that were adapted to serum-free suspension culture, were maintained in CDM4HEK293 medium (HyClone) supplemented to contain 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mM L-glutamine, 2 mM L-alanyl-L-glutamine dipeptide, 0.25 lg/ml amphotericin B, and 1:1,000 (v:v) anti-clumping agent (Life Technologies). Suspension culture-adapted cells were propagated in either 1,050 cm 2 smooth surface roller bottles (Thermo Scientific) or a 14 l autoclavable bioreactor supported by a New Brunswick BioFlo 310 benchtop fermentor system (Eppendorf) http:// newbrunswick.eppendorf.com/en/products/fermentors/.
Generation of Recombinant CFTR Cell Lines
The 293T/17 cell line (ATCC Ò ) used for packaging of all lentiviral vector stocks was maintained in DMEM supplemented to contain 10 % FBS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. Lentiviral vector genomes containing the different CFTR genetic recombinants were packaged by cotransfecting 293T/17 cells with pCMVDR8.2 packaging plasmid DNA and vesicular stomatitis virus envelope glycoprotein plasmid DNA [24, 43] . Culture supernatants were collected after 60 h, clarified by low-speed centrifugation (2509g, 10 min), filtered through 0.45-lm sterile filters, and concentrated by ultracentrifugation at 125,0009g at 4°C for 2 h. For transduction, 10 5 HEK293.M2 (D017) cells in 200 ll of DMEM/F12/1 % FBS were incubated with concentrated packaged vector at 37°C for 18 h. After 2-3 days, 1 lg/ml dox was added to the culture medium, and 24 and 48 h later, transgene expression was assessed by fluorescence microscopy. Cultures exhibiting a positive response in less than 40 % of the cell population were discarded. Those with favorable expression were cultured for 7-9 days in the presence of 10 lg/ml puromycin. All selected cell cultures were confirmed to be [95 % expression-positive for the respective transgene by monitoring either EGFP or CFTR as described below. Puromycin-selected cell populations were expanded in the absence of dox and puromycin and cryopreserved in liquid nitrogen. Subsequent studies of the different CFTR cell lines were performed with monolayer cultures, except where suspension culture-adapted cells have been specified.
Western Blot Analysis
Western blot analysis of cells expressing recombinant CFTR was performed using methods reported earlier [44, 45] . Briefly, cells were solubilized in sample buffer [46] , sonicated, and heated at 37°C for 5 min prior to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 7 % gels. Proteins were transferred to nitrocellulose by electroblotting and detected using either antiRGSHis 4 (Qiagen) or R1104 anti-CFTR mouse monoclonal antibody recognizing an epitope comprising amino acids 722-734 in the CFTR regulatory (R) region [47] . Horseradish peroxidase-conjugated goat anti-mouse IgG (Southern Biotech) was used as secondary antibody with Immobilon Western Chemiluminescent substrate (Millipore). The chemiluminescent signal was captured and analyzed on an ImageQuant LAS 4000 Mini luminescent image analyzer (GE Healthcare Life Sciences).
Flow Cytometry
Cellular expression and plasma membrane compartmentalization of CFTR were analyzed using flow cytometry to detect EGFP expression and FLAG immunostaining. Live cells were equilibrated in room temperature (RT) staining buffer for 15 min, incubated with 5 lg/ml of SureLight APC anti-FLAG M2 mAb for 30 min at RT, washed three times with ice-cold staining buffer, detached by incubation on ice with phosphate-buffered saline containing 0.5 mM EDTA, washed once with staining buffer, and resuspended in 200 ll Cytofix (BD Biosciences). Both EGFP fluorescence and FLAG/CFTR staining were measured using a BD FACSCalibur or LSRII flow cytometer (BD Biosciences). Negative/positive fluorescence boundaries were determined using HEK293.M2 cells. Flow cytometric data were analyzed using FlowJo software.
Derivation of Clonal Cell Cultures
All recombinant CFTR cell lines analyzed in this study comprised mass populations of transduced cells unless otherwise noted. To generate clonal cell lines, cultures treated for 18-24 h with 1 lg/ml of dox were live-stained using SureLight allophycocyanin (APC)-conjugated anti-FLAG M2 (PerkinElmer). The most highly fluorescent cells (top 10 %) were sorted individually into wells of 96-well plates using a FACS Aria (BD Biosciences). Initial screening of clonal cell cultures included analyses of cellular morphology, growth kinetics, and levels of basal and dox-induced EGFP and/or FLAG/CFTR expression using fluorescence microscopy. Clonal cultures exhibiting favorable characteristics were expanded for further analyses and cryopreservation of master stocks. Clonal cell lines adapted to serum-free suspension culture were reanalyzed to ensure growth kinetics. Relative CFTR expression levels in suspension culture-adapted cells were not predictable based on the analysis of the corresponding monolayer cells, and therefore, CFTR expression properties were redetermined in each instance. To confirm the integrity of the recombinant CFTR sequence in the D165 clonal line, PCR amplicons comprising the SUMO*-CFTR FLAG -EGFP open reading frame were generated by PCR, sequenced without cloning, and found to be identical to the transducing vector (data not shown).
Single-Channel Recording
Microsomal membrane fractions were prepared from the HEK293-derived cell lines overexpressing CFTR recombinant proteins or from BHK cells constitutively expressing wtCFTR, as described previously confirm citation [48] . Membrane vesicles were phosphorylated by incubation with 50 nM PKA catalytic subunit (Promega) and 2 mM Na2ATP (Sigma-Aldrich) in 10 mM Hepes, pH 7.2, 0.5 mM EGTA, 2 mM MgCl 2 , and 250 mM sucrose at RT for 15 min. Aliquots were stored at -80°C until used. Microsomal vesicles were fused to planar lipid bilayers and single-channel currents were recorded at 30°C in symmetrical buffer (300 mM Tris HCl pH 7.2, 3 mM MgCl 2 , 1 mM EGTA) at -75 mV under voltage-clamp conditions as described previously [49] . To maintain uniform channel orientation and optimal functional state, 2 mM Na2ATP, 50 nM PKA ,and 10 ll membrane vesicles were added to the one side of the bilayer only. Output signal was filtered with a cut-off frequency of 50 Hz.
Fluorescence Microscopy
Cells in 8-chamber glass slides (Falcon CultureSlide) coated with bovine type I collagen (BD Biosciences) were treated with dox for 24 h. Live cells were immunostained without fixation by incubation on ice with 5 lg/ml anti-FLAG M2 mAb (Sigma-Aldrich) followed by cold washing and incubation with Alexa Flur Ò 594-conjugated goat anti-mouse IgG (H ? L) antibody (Life Technologies) on ice for 30 min. Cells were washed with cold-staining buffer (BD Biosciences), and then fixed for 15 min with Cytofix (BD Biosciences). Cells were washed, cured with ProLong Ò Gold antifade reagent containing 4 0 ,6 0 -diamidino-2-phenylindole (DAPI) (Life Technologies) to stain cell nuclei, and mounted with a coverslip. Confocal images were acquired using a Zeiss LSM 710 confocal microscope with a 639 PlanApo oil immersion objective at a resolution of 1,024 9 1,024 pixels. A Helium Neon 561 nm excitation laser was used to excite Alexa Flur Ò 594 and image spectra at 590-700 nm. Optical sections in the z-axis (z-stack) were acquired at 0.45-micron intervals. Images of DAPI-stained cell nuclei (blue) were acquired using a 405 nm laser. For protein colocalization studies, fluorescence was analyzed using a Nikon Eclipse TE2000-S inverted microscope equipped with an Xcite 120 Fluorescent Illumination system. Images were captured and analyzed using a SPOT RT3 25.4 Color Slider camera (Diagnostics Imaging, Inc., SPOT TM Imaging Solutions division) supported with Qcapture Pro software (QImaging, Inc.).
Mass Spectrometry Quantitation of Cell-Surface CFTR Heavy isotope-labeled CFTR was prepared from baby hamster kidney (BHK) cells expressing wtCFTR as described previously [50] using 99 % atom-enriched 1,2-[ 13 C] 2 -L-leucine as the isotope-labeled amino acid. A purified CFTR external standard was used to determine concentrations of labeled CFTR present in Triton X-100 cellular extracts prepared from the BHK cells [50] . To specifically quantify CFTR compartmentalized in the plasma membrane, intact cells were surface biotinylated and biotinylated protein was isolated using the EZ-Link Sulfo-NHS-SS-Biotin kit (Thermo Scientific). Protein fractions (biotinylated protein or Triton X-100 cell extracts) were spiked with the L-leucine isotope-labeled cell lysate, and then subjected to SDS-PAGE, in-gel protein digestion and peptide cleanup as previously described previously [50] . Three human CFTR signature peptides designated CFTR01, CFTR02, and CFTR04 of the sequences shown in Table 1 were used to quantify the isolated CFTR protein fractions using liquid chromatography multiple reaction monitoring-mass spectrometry [50, 51] . The instruments used were an Eksigent NanoLC-ultra 2D Plus liquid chromatograph and 4000 QTrap mass spectrometer (ABSCIEX).
CFTR Purification SUMO*-CFTR FLAG -EGFP was solubilized from microsomal membranes with n-dodecyl-b-D-maltoside (DDM) and affinity purified using NiNTA resin (Qiagen) according to manufacturer-recommended procedures. In-gel fluorescence with external standards was used to quantify SUMO*-CFTR FLAG -EGFP in crude and purified fractions [52] . Samples were resolved on 8 % SDS-PAGE gels together with known amounts of SUMO-EGFP fusion protein (39 kD, LifeSensors). Fluorescence of EGFP-tagged proteins was imaged using a Typhoon scanner (GE Healthcare), and densitometry of fluorescent bands was performed in ImageJ (http://imagej.nih.gov/ij/).
Fluorescence Size-Exclusion Chromatography (FSEC) FSEC of purified SUMO*-CFTR FLAG -EGFP was performed on a 3.2 mm 9 30 cm Superose 6 column (GE Healthcare) in 50 mM Tris Cl pH 7.5, 0.15 M NaCl, 10 % glycerol, 2.5 mM MgCl 2 , 0.05 % DDM, 0.2 mM tris(2-carboxyethyl)phosphine, flowing at 0.04 ml/min. EGFP fluorescence was monitored at 488 nm/509 nm using a Jasco FP2020 Plus fluorimetric detector, with gain set at 100 and attenuation at 64.
Results
Analysis of Recombinant CFTR Protein Expression
To explore the utility and performance of various in-frame domain fusions of recombinant CFTR, the HEK293.M2 cell line [41] was transduced with either the SUMO*-CFTR FLAG -EGFP, SUMO*-CFTR-EGFP, CFTR FLAG -EGFP, CFTR FLAG , or wtCFTR expression vector (Fig. 1) . The resulting cultures were induced with dox for 24 h, and CFTR expression was analyzed by Western blot (Fig. 2) . Replicate blots were probed with either anti-CFTR mAb (R1104) or N-terminal-specific anti-RGSHis 4 mAb. SUMO*-CFTR FLAG -EGFP, CFTR FLAG , and CFTR proteins were detected at similar levels and slightly higher than CFTR FLAG -EGFP (lane 4). SUMO*-CFTR FLAG -EGFP (lane 1) resolved into a double band, indicating expression of both core-glycosylated (band B) and complex-glycosylated (band C) CFTR. Greater electrophoretic mobility of CFTR FLAG compared to CFTR was evident on SDS-gels (lane 6 vs. 5, also lane 1 vs. 2) and is likely due to disruption of one of the two glycosylation sites caused by insertion of the FLAG epitope [33, 34, 53, 54] . The CFTR FLAG -EGFP protein exhibited both bands B and C (lane 4), while wtCFTR and CFTR FLAG (lanes 5 and 6, respectively) were expressed at high levels with a predominance of band C. Cells expressing the DF508 form of SUMO*-CFTR FLAG -EGFP (lane 3) exhibited reduced expression of band C, consistent with expectations for this CFTR mutant to be retained in the endoplasmic reticulum (ER) in its core-glycosylated form [4, 55] . D165 (lane 7) is a clonal derivative of the SUMO*-CFTR FLAG -EGFP cell population (lane 1), which exhibited a similar immunoblot phenotype. These results provided qualitative evidence that the cell expression system utilized can produce recombinant CFTR containing various tags, including the multiply tagged SUMO*-CFTR FLAG -EGFP recombinant protein. Cells expressing CFTR FLAG , CFTR FLAG -EGFP, SUMO*-CFTR FLAG -EGFP (D158), and its clonal derivative (D165), were analyzed using flow cytometric methods to compare CFTR expression levels and surface compartmentalization. Cells transduced with CFTR FLAG stained positive for the FLAG epitope, and each of the CFTR FLAG -EGFP-containing cell lines was decidedly positive for both EGFP and FLAG staining (Fig. 3a) . Importantly, since immunostaining was performed on live/intact cells, positive FLAG staining indicated compartmentalization of the recombinant CFTR protein in the plasma membrane (and see Fig. 5 ). The overall magnitude of EGFP and FLAG-stain fluorescence was reproducibly greater for SUMO*-CFTR FLAG -EGFP (both D158 and D165 cell lines) compared to CFTR FLAG -EGFP, possibly due to enhanced stability. Similarly, cell-surface FLAG staining of CFTR FLAG appeared to be greater than that of CFTR (Fig. 3b) . Mean fluorescence intensity (MFI) values for SUMO*-CFTR FLAG -EGFP were greater at each time point compared to CFTR FLAG -EGFP, with the greatest difference observed 24 h after induction. These differences in surface CFTR expression level were consistent with the degree of complex glycosylation observed by Western blot analysis (Fig. 2) . These results suggest that introducing the N-terminally fused SUMO* domain to CFTR FLAG -EGFP increased its cell-surface expression of the protein.
Channel Activity of CFTR in Cell Membranes
Single-channel recording provides a means to validate function of recombinant CFTR function [56, 57] . Expressed wtCFTR in BHK and HEK cell lines (Fig. 4) exhibited single-channel conductance (c of 12.3 ± 0.1 pS (n = 6) and 12.2 ± 0.1 pS (n = 7), respectively. Slight differences in conductance and gating kinetics were not significant, indicating the channel properties of untagged wtCFTR were independent of the cell line in which it was expressed. Modification of CFTR with both SUMO* and EGFP tags (Fig. 4) did not affect single-channel conductance, but approximately doubled the mean closed time (s c ) with no significant change in the mean open time (s o ). As a result, the open probability (P o ) decreased approximately twofold, to 0.26. CFTR FLAG exhibited a single-channel conductance of 11.5 ± 0.1 pS (n = 7), which was a statistically significant reduction compared to wt CFTR (P \ 0.05) and could reflect the influence of additional negative charge (due to FLAG sequence, DYKDDDDK) near the outer vestibule. P o and gating kinetics of CFTR FLAG were essentially the same as those of the SUMO*-CFTR-EGFP construct. The CFTR construct containing all three tags, SUMO*-CFTR FLAG -EGFP, had the same conductance as CFTR FLAG and gating kinetics typical of the individually SUMO*-or FLAG-tagged constructs. The influence of the latter two modifications on gating kinetics was not additive.
Microscopic Visualization of CFTR Surface Localization
Expression of recombinant SUMO*-CFTR FLAG -EGFP protein was initially analyzed by immunofluorescence confocal microscopy. Dox-induced cells, live-stained to specifically detect surface FLAG, exhibited a strong fluorescence pattern particularly evident along the cell periphery. A z-stack of acquired images illustrates a strong punctate pattern of FLAG staining (red) that is broadly distributed across the cells (Fig. 5a ). The control non-FLAG-stained cells exhibited no Alexa Flur Ò fluorescence (data not shown). In fluorescence microscopy colocalization experiments, FLAG immunostaining (red) was detected with live-stained cells expressing SUMO*-CFTR FLAG -EGFP (Fig. 5b) , but not (FLAG-less) SUMO*-CFTR-EGFP cells (Fig. 5c ). In each cell type, EGFP was detected throughout the cell (green), with the brightest areas of fluorescence appearing along portions of the cell periphery and at cell-cell interfaces. Merging the FLAG and EGFP fluorescent images demonstrated extensive colocalization of the two domains at the plasma membrane. FLAG immunostaining of fixed, permeabilized cells expressing SUMO*-CFTR FLAG -EGFP (Fig. 5d ) demonstrated a subcellular localization pattern similar to that of EGFP, further establishing colocalization of EGFP with CFTR protein.
These results indicate compartmentalization at the plasma membrane of the recombinant SUMO*-CFTR FLAG -EGFP protein.
Quantitative Analysis of CFTR Expression by Mass Spectrometry
Since the rtTA-M2 enables incremental control of transcription, SUMO*-CFTR FLAG -EGFP expression was induced by treating cells with different concentrations of dox, ranging from 0.0007 to 0.5 lg/ml. Cells were collected after 24 h and analyzed for surface CFTR. Flow cytometric analysis demonstrated a dose-response effect of dox concentration on surface FLAG/CFTR expression level (Fig. 6a) . Samples from the same cultures were further analyzed by surface biotinylation and mass spectrometry to quantify surface CFTR. In this experiment, cell-surface CFTR levels plateaued at *400 lg per 10 9 cells, or 1.1 9 10 6 molecules CFTR per cell (Fig. 6b) . In three independent experiments, the average maximum induced level of surface CFTR was 363 ± 31 lg per 10 9 cells. The average level of total cellular CFTR was 3,581 ± lg per 10 9 cells (Table 2) . Thus, when overexpressed at these high levels, *1/10th of the CFTR synthesized was present on the cell surface. Over the range of dox concentrations analyzed, there was a very strong linear correlation (r 2 = 0.961) between mass spectrometric and flow cytometric measurements of cell-surface SUMO*-CFTR FLAG -EGFP (Fig. 6c) . These results indicated that HEK293.M2 cells biosynthesize and traffic appreciable quantities of recombinant CFTR to the plasma membrane, and flow cytometry of cells live-stained for the FLAG epitope can be used to assess CFTR surface expression. 
Demonstration of CFTR Purification Using a Mild Detergent
Inclusion of EGFP in the recombinant SUMO*-CFTR FLAG -EGFP protein makes it possible to quantify CFTR even in crude cell lysates using in-gel fluorescence [52] . We applied this method to quantify SUMO*-CFTR-EGFP in microsomal membranes and monitor its recovery through the trial protein purification as shown in Fig. 7 . The starting material, a microsomal fraction of 0.15 9 10 9 cells harvested from a 1 liter serum-free suspension-culture, contained 235 lg of SUMO*-CFTR FLAG -EGFP (1,600 lg per 10 9 cells). DDM is a preferred mild detergent for structural biology, but it has been successfully applied for CFTR purification only with low-expressing mammalian cell lines [57, 58] . Extraction of microsomes with DDM solubilized 221 lg of SUMO*-CFTR FLAG -EGFP (1,470 lg per 10 9 cells) (Fig. 7a) . With this abundant starting material, and taking advantage of the engineered His 10 -tag, NiNTA affinity chromatography was employed to isolate 42 lg SUMO*-CFTR CFTR -EGFP (280 lg per 10 9 cells) with an overall recovery of 18 % (Fig. 7a) . Coomassie blue staining of the same gel indicated that *80 % pure CFTR was achieved in a single chromatography step (Fig. 7b) .
These same procedures were used to quantify SUMO*-CFTR FLAG -EGFP recoveries in replicate purification trials. We found a mean value of 1,365 lg of SUMO*-CFTR FLAG -EGFP per 10 9 cells in microsomal preparations from multiple batches of D165 cultures (Table 2) . Of this, DDM solubilization and NiNTA affinity chromatography yielded 905 and 178 lg, respectively, per 10 9 cells (Table 2) , representing average overall CFTR recoveries of 66 and 13 %, respectively. Purity of *80 % was consistently observed (data not shown). Potential aggregation of the purified SUMO*-CFTR FLAG -EGFP was assessed by FSEC. The SUMO*-CFTR FLAG -EGFP protein was eluted as a single, nearly symmetric peak without evidence of aggregated protein at the void volume (Fig. 8) . The observed position of the peak would be consistent with either monomer or dimer. In a recent study, SUMO*-CFTR FLAG -EGFP purified using similar procedures was active and appeared monomeric by cryo-electron microscopy [59] . These results indicated that functional SUMO*-CFTR FLAG -EGFP can be readily isolated from D165 cells in relative abundance using a mild detergent and without overt aggregation, suggesting the HEK293 mammalian cell culture system described in this study can provide a rich source of quality human CFTR protein for future biophysical investigation.
Discussion
The challenge of obtaining human CFTR in sufficient quantities for biophysical studies is multifactorial and persists as a fundamental obstacle to structure-based CF drug discovery. Mammalian cell expression systems offer the advantage of a physiologically relevant context for CFTR biogenesis so as to preserve native protein folding and post-translational modification [29] . CFTR expressed constitutively in BHK cells retains chloride-channel function [57] , however, the cells produce only modest amounts of CFTR. In this study, we approached surmounting this obstacle by describing a linearly integrated strategy for modification of the protein and for evaluating its function and biogenesis in mammalian cells, as well as enabling production and isolation of mature, biologically active human CFTR in preparative amounts.
The TRE-SUMO*-CFTR FLAG -EGFP-IRES-Puro expression strategy (Fig. 1a) comprises several important features that facilitate consistent production of highquality recombinant human CFTR protein in mammalian cells. Expression of CFTR is tightly regulated using the Tet-On system [60] . The HEK293.M2 (D017) cells used in this study express an enhanced rtTA that is stable in eukaryotic cells, exerts minimal basal expression from the TRE promoter and is capable of inducing high-level transactivation of gene expression upon dox binding [61] . We have found the inducible expression approach circumvents transcriptional silencing of CFTR observed in HEK293 cell cultures when expression was driven constitutively by the CMV promoter (unpublished results).
With dox-controlled expression, CFTR-transduced HEK293 cells grow more rapidly and reach higher densities prior to induction compared to constitutively expressing HEK293 cells. The inducible expression strategy also facilitates the generation and procurement of characterized master-stock recombinant cell lines with stable genetic and biological properties. Thus, the strategy of controlled CFTR expression is vital for optimal maintenance and expansion of ''quiescent'' cells, as well as for maximizing CFTR production on a per-cell basis in response to dox. Indeed, in the case of SUMO*-CFTR FLAG -EGFP, mass-spectrometric analysis indicated CFTR expression levels in the mg per 10 9 cell range, approximately 1/10th of which was cell-surface localized even when overexpressed to these high levels. This expression system will, therefore, enable large-scale suspension cell cultures to be grown and induced under carefully optimized and standardized conditions to produce sufficient quantities of CFTR for biophysical studies.
Recording single-channel activity provides an informative measure of CFTR function, and is traditionally used to evaluate function of recombinant CFTR proteins expressed Fig. 8 Monodispersity of affinity-purified SUMO*-CFTR FLAG -EGFP. Protein eluted from NiNTA (25 ll containing 1.7 lg CFTR) was analyzed by FSEC on a 2.4 ml column. The peak of SUMO*-CFTR FLAG -EGFP (212 kDa) was eluted at 1.62 ml, near that of the monomeric P-glycoprotein-EGFP fusion protein (172 kDa), at 1.73 ml that is routinely used as a standard with FSEC assays. The arrow indicates the column void volume at 1.05 ml in various cell lines [56, 57] . In this study, we identified combinations of heterologous tags/domains that add utility without seriously altering CFTR gating parameters or singlechannel conductance (Fig. 4) . The C-terminal EGFP and N-terminal SUMO* fusions were both functionally silent, while the extracellular loop FLAG insertion caused a slight decrease in single-channel conductance, whether alone or in the CFTR construct containing all three tags, SUMO*-CFTR FLAG -EGFP. Nevertheless, the differences in the gating kinetics and single-channel conductance found between the unmodified and tagged CFTR variants were not dramatic, suggesting they have the same folded state.
Recombinant SUMO fusion proteins exhibit enhanced expression, decreased susceptibility to proteolytic degradation, and improved folding in E. coli and yeast [36, 37] . For CFTR fusion, we utilized the SUMO* variant containing R64T and R71E mutations to prevent its cleavage by eukaryotic proteases [39] . Analysis of the N-terminus of the fusion proteins by immunoblotting with anti-RGSHis 4 mAb suggested that SUMO*-CFTR fusions were intact in HEK cells (Fig. 2) . The presence of this domain proved advantageous for CFTR biogenesis in our system, since the comparative expression analysis indicated a 1.5-to 2-fold increase in surface levels of SUMO*-CFTR FLAG -EGFP compared to CFTR FLAG -EGFP (Fig. 3b) . If necessary for downstream applications, the SUMO* tag is removable with the highly specific SUMO* protease [36] .
Cell-surface localization of CFTR is important due to multiple quality control checkpoints that preclude improperly folded CFTR from reaching this compartment [6] . However, since extracellular loops of CFTR are relatively small and poorly exposed, high-avidity antibody probes to extracellular regions of the protein are not available for use in cell-surface compartmentalization analyses [33] . Positioning a FLAG epitope tag in the fourth extracellular loop of CFTR enabled sensitive and specific analysis of CFTR cell-surface compartmentalization and augmented the derivation of high-producer cell lines. Insertion of FLAG at this site disrupts one of two N-glycosylation sites located in this loop, and band patterns in the immunoblot analysis (Fig. 2) were consistent with hemiglycosylation of FLAG-tagged CFTR variants. Previous studies indicated that this tag placement did not compromise plasma membrane compartmentalization of CFTR or channel function [33, 34] . We confirmed that FLAG-tagged variants, including those with a SUMO* N-terminal fusion, traffic successfully to the cell surface, and channel function was essentially intact with only a small decrease in conductance. Cell-surface FLAG/CFTR was quantifiable by flow cytometry, and this signal correlated strongly with cell-surface CFTR measurements made by mass-spectrometric analysis of surface-biotinylated CFTR (Fig. 6c) . We also used FACS to specifically isolate the highest surface FLAG/CFTR-expressing cells from the transduced population. We found this to be a specific and efficient means to derive clonal cultures (such as D165) with favorable expression characteristics from among a diverse population, and we have recently extended the approach to facilitate studies of cell lines expressing CFTR orthologs (unpublished).
The C-terminal fusion of EGFP is especially useful for both real-time monitoring of CFTR expression in live cultures and rapid evaluation of subcellular distribution by fluorescence microscopy. Flow cytometry of GFP fluorescence may be used for quantitation and facilitates cell sorting to isolate highly expressing subpopulations and derivation of clonal cell lines. Downstream, EGFP proved invaluable for CFTR quantitation both in crude cell lysates and successive protein purification steps. Using quantitative in-gel fluorescence methods, our results show that microsomal membranes contained 1.4 mg of SUMO*-CFTR FLAG -EGFP per 10 9 D165 suspension cells ( Table 2) . From this starting material, using standard methods of detergent solubilization and affinity purification, we recovered 180 lg CFTR per 10 9 cells at *80 % purity. Moreover, FSEC demonstrated that purified SUMO*-CFTR FLAG -EGFP was monodisperse (Fig. 8 ). These and recently published results [59] indicate that SUMO*-CFTR FLAG -EGFP can be readily isolated and purified in relative abundance, suggesting the mammalian cell culture system described here can provide a rich source of quality CFTR for biophysical investigations.
Our findings describe the development and validation of a robust mammalian cell expression system that facilitates reproducible and standardized large-scale production of exogenous, biologically active cell surface human CFTR protein. Importantly, the molecular expression strategy we used is vertically integrated to enhance efficiency and augment identification and derivation of stable high-producer cells, improve reproducibility and standardization of lot production, and facilitate analytical assessment at multiple steps from surface expression and cell isolation to monitoring of SUMO*-CFTR FLAG -EGFP solubilization and purification. With this expression platform in place, we anticipate that future studies with stabilizing mutations and CFTR orthologs will inform research efforts to stabilize the CFTR protein, as a prerequisite for the solution of its structure.
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